Sven-Erik Dahlén - Publications#


Some 350 publications have been cited more than 13,500 times with h-factor 52 for the original publications.
2 papers > 1000 times cited and 17 papers > 200 times cited

Selection of publications representing different areas of Sven-Erik Dahlén's work:

1. Dahlén S-E, Hedqvist P, Hammarström S, Samuelsson B: Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288:484-486.

2. Dahlén S-E, Björk J, Hedqvist P, Arfors K-E, Hammarström S, Lindgren JÅ, Samuelsson B: Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillry venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981;78:3887-3891.

3. Dahlén S-E, Hansson G, Hedqvist P, Björck T, Granström E, Dahlén B: Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4. Proc Natl Acad Sci USA 1983;80:1712-1716.

4. Raud J, Dahlén S-E, Sydbom A, Lindbom L, Hedqvist P: Enhancement of acute allergic inflammation by indomethacin is reversed by Prostaglandin E2: Apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 1988;85: 2315-2319.
5. Dahlén B, Kumlin M, Margolskee DJ, Larsson C, Blomqvist H, Zetterström O, Williams VC, Dahlén S-E: The leukotriene-antagonist MK-0679 blocks aspirin-induced airway obstruction induced by bronchial provocation with Lysine-aspirin in aspirin-sensitive asthmatics. Eur Resp J 1993; 6: 1018-1026

6. O'Sullivan S, Kumlin M, Dahlén B, Dahlén S-E: Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 following aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
J Allergy Clin Immunol 1996;98:421-432.

7. Roquet A, Dahlén B, Kumlin M, Ihre E, Anstrén G, Binks S, Dahlén S-E: Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
Am J Resp Crit Care Med 1997;155:1856-1863.

8. Kupczyk M, Haque S, Sterk PJ, Nizankowska-Mogilnicka E, Papi A, Bel EHD, Chanez P, Dahlén B, Gaga M, Gjomarkaj M, Howarth PH, Johnston SL, Joos GF, Kanniess F, Tzortzaki E, Middelveld RJM, Dahlén S-E on behalf of the BIOAIR investigators. Detection of exacerbations in asthma based on electronic diary data - results from a one year prospective study. Thorax 2013; 68:611-8.

9. Säfholm J, Manson M, Bood J, Delin I, Orre A-C, Bergman P, Al-Ameri M, Dahlén S-E, Adner M: Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in small human airways via the EP2 receptor. J Allergy Clin Immunol 2015; 136:1232-1239.

10. James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Shoichiro O, Izuhara K, Bel EH, Söderhäll C, Dahlén B, Boot RG, Dahlén SE. The Chitinase Proteins YKL-40 and Chitotriosidase are Increased in Both Asthma and COPD. Amer J Res Crit Care Med 2016;193:131-42.
Imprint Privacy policy « This page (revision-2) was last changed on Thursday, 5. January 2017, 10:22 by Kaiser Dana
  • operated by